{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:47:24Z","timestamp":1791924444822,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tjpad.2026.100680","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:29:16Z","timestamp":1791833356000},"page":"100680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological interventions for reducing the risk of cognitive decline and dementia after stroke\/transient ischemic attack: A systematic review"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3392-8207","authenticated-orcid":false,"given":"Colin","family":"Rosenau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-7018","authenticated-orcid":false,"given":"Lieke","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8240-5367","authenticated-orcid":false,"given":"Veerle","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-0609","authenticated-orcid":false,"given":"Sebastian","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-2974","authenticated-orcid":false,"given":"Kay","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.tjpad.2026.100680_bib0001","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100680_bib0002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/17474930211065917","article-title":"World Stroke Organization (WSO): global Stroke Fact Sheet 2022","volume":"17","author":"Feigin","year":"2022","journal-title":"Int J Stroke"},{"issue":"20 Suppl 2","key":"10.1016\/j.tjpad.2026.100680_bib0003","first-page":"S6","article-title":"Global epidemiology of stroke and access to acute ischemic stroke interventions","volume":"97","author":"Saini","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100680_bib0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1747-4949.2012.00942.x","article-title":"Top 10 research priorities relating to life after stroke\u2013consensus from stroke survivors, caregivers, and health professionals","volume":"9","author":"Pollock","year":"2014","journal-title":"Int J Stroke"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100680_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jamaneurol.2021.5080","article-title":"Association of ischemic stroke incidence, severity, and recurrence with dementia in the atherosclerosis risk in communities cohort study","volume":"79","author":"Koton","year":"2022","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100680_bib0006","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3233\/JAD-220317","article-title":"Dementia risk following ischemic stroke: a systematic review and meta-analysis of factors collected at time of stroke diagnosis","volume":"90","author":"Waziry","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100680_bib0007","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/S2666-7568(23)00217-9","article-title":"Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis","volume":"5","author":"Filler","year":"2024","journal-title":"Lancet Healthy Longev"},{"issue":"25","key":"10.1016\/j.tjpad.2026.100680_bib0008","first-page":"3326","article-title":"Vascular cognitive impairment and dementia: JACC scientific expert panel","volume":"73","author":"Ladecola","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100680_bib0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12883-023-03120-x","article-title":"Transient cognitive impairment in the acute phase of stroke - prevalence, risk factors and influence on long-term prognosis in population of patients with stroke (research study - part of the PROPOLIS study)","volume":"23","author":"Dros","year":"2023","journal-title":"BMC Neurol"},{"key":"10.1016\/j.tjpad.2026.100680_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12883-015-0288-2","article-title":"Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study","volume":"15","author":"Mellon","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.tjpad.2026.100680_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9780067","article-title":"Antiplatelets and vascular dementia: a systematic review","volume":"2022","author":"Alexander","year":"2022","journal-title":"J Aging Res"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100680_bib0012","article-title":"Anticoagulants and dementia: a systematic review","volume":"15","author":"Kalloo","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100680_bib0013","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000533283","article-title":"Association of Aspirin with dementia or mild cognitive impairment: a systematic review and meta-analysis of randomized trials","volume":"57","author":"Xie","year":"2023","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tjpad.2026.100680_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100962","article-title":"Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: a systematic review and meta-analysis","volume":"57","author":"Yang","year":"2020","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.tjpad.2026.100680_bib0015","unstructured":"WHO. WHO handbook for guideline development. 2nd ed. World Health Organization; 2014. Chapter 8."},{"issue":"9","key":"10.1016\/j.tjpad.2026.100680_bib0016","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"12","key":"10.1016\/j.tjpad.2026.100680_bib0017","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1111\/ene.15068","article-title":"European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment","volume":"28","author":"Quinn","year":"2021","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100680_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164608","article-title":"Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: main results from the pilot 'Prevention of decline in cognition after stroke trial' (PODCAST) Randomised controlled trial","volume":"12","author":"Bath","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.tjpad.2026.100680_bib0019","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","volume":"7","author":"Diener","year":"2008","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.tjpad.2026.100680_bib0020","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ebiom.2015.08.006","article-title":"The Japan Statin treatment against recurrent stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study","volume":"2","author":"Hosomi","year":"2015","journal-title":"eBioMedicine"},{"issue":"12","key":"10.1016\/j.tjpad.2026.100680_bib0021","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S1474-4422(14)70224-8","article-title":"Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial","volume":"13","author":"Pearce","year":"2014","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.tjpad.2026.100680_bib0022","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100680_bib0023","article-title":"Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack","volume":"7","author":"Zonneveld","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tjpad.2026.100680_bib0024","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2377-12-88","article-title":"Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Neurol"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100680_bib0025","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaneurol.2016.0955","article-title":"Risk factors associated with early vs delayed dementia after intracerebral hemorrhage","volume":"73","author":"Biffi","year":"2016","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100680_bib0026","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12877-020-01760-z","article-title":"Can cardiovascular risk management be improved by shared care with general practice to prevent cognitive decline following stroke\/TIA? A feasibility randomised controlled trial (SERVED memory)","volume":"20","author":"Davison","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.tjpad.2026.100680_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2020.549265","article-title":"Acupuncture for improving cognitive impairment after stroke: a meta-analysis of randomized controlled trials","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Psychol"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100680_bib0028","article-title":"Virtual reality for stroke rehabilitation","volume":"6","author":"Laver","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tjpad.2026.100680_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419878317","article-title":"Repetitive transcranial magnetic stimulation in stroke rehabilitation: review of the current evidence and pitfalls","volume":"12","author":"Fisicaro","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"issue":"12","key":"10.1016\/j.tjpad.2026.100680_bib0030","article-title":"Traditional Chinese herbal medicine for vascular dementia","volume":"12","author":"Chan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100680_bib0031","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/15701611113119990119","article-title":"Vitamin D and stroke: promise for prevention and better outcome","volume":"12","author":"Makariou","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"issue":"11","key":"10.1016\/j.tjpad.2026.100680_bib0032","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery","volume":"11","author":"Legg","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100680_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227820","article-title":"Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: a meta-analysis","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100680_bib0034","article-title":"Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia","volume":"7","author":"Kwan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100680_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13311-011-0047-z","article-title":"Vascular cognitive impairment: disease mechanisms and therapeutic implications","volume":"8","author":"Levine","year":"2011","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100680_bib0036","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"Rouch","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tjpad.2026.100680_bib0037","doi-asserted-by":"crossref","DOI":"10.1590\/1980-5764-dn-2023-0116","article-title":"Vascular cognitive impairment and dementia: a narrative review","volume":"18","author":"Jim\u00e9nez-Ruiz","year":"2024","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.tjpad.2026.100680_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c3666","article-title":"The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"341","author":"Debette","year":"2010","journal-title":"BMJ"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:07:18Z","timestamp":1791922038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2274580726002037"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100680","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological interventions for reducing the risk of cognitive decline and dementia after stroke\/transient ischemic attack: A systematic review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100680"}}